Cannabis Law Report

AUGUST 26, 2022

Several companies are facilitating the development of this product. More research is still needed to explore this uncharted territory. CBD has been suggested to act as a treatment for sclerosis symptoms, as well as epilepsy among children. However, deeper research is needed to better understand its roles.

Epilepsy 52

Epilepsy Treatment CBD Sleep 52

MMJ Recs

NOVEMBER 20, 2023

These two cannabinoids represent just a fraction of the compounds within the cannabis plant, and ongoing research continues to uncover the potential of other lesser-known cannabinoids. Additionally, they may help slow the growth of certain types of cancer cells, though further research is needed.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

WeedAdvisor

JANUARY 8, 2019

For decades, marijuana for cancer treatment seemed out of the question. The drug’s status as a controlled substance meant that research into its anti-tumour potential was sparse. While research into the topic is rare, it is not non-existent. The Endocannabinoid System in Cannabis Cancer Treatment.

Treatment 75

Treatment Research and Development Cannabinoids THC 75

Cannabis Law Report

JANUARY 15, 2019

British firm GW Pharmaceuticals is licking its wounds after US judges tossed out its attempt to patent multiple cannabinoids for epilepsy treatment following an eight-year battle. The patent, which has been embroiled in dispute since 2010, is for “the use of one or more cannabinoids in the treatment of epilepsy”.

Epilepsy 71

Epilepsy Cannabinoids Treatment Research and Development 71

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Cancer patients suffer not only from cancer, but the damaging effects of treatment. Cannabis Cancer Treatments as an Alternative to Opioids.

Treatment 49

Treatment Clinical Trials Research and Development Cannabinoids 49

Leaf Science

FEBRUARY 19, 2019

When using mice who had been selectively bred to develop symptoms associated with depression (such as lethargy and immobility), researchers found that CBD treatment was linked to a reduction in immobility during a forced swim test, a commonly used test used to study depressive symptoms. CBD and Traditional Antidepressants.

CBD 101

CBD Research and Development Treatment Epilepsy 101

Sensi Seeds

DECEMBER 10, 2018

At the same time, research on medical cannabis over the past two decades has not ceased to increase and provide evidence of the plant’s medical value. As a result, medical and scientific research has been highly constrained for many decades. Exponential Increase in Cannabis Research: Trends.

Medicine 81

Medicine Research and Development Data Policy 81

MGC Pharma

APRIL 4, 2018

A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals. CBD-based treatment for people with Refractory Epilepsy?—?is Refractory Epilepsy is epilepsy that involves frequent and severe seizures that are difficult to treat. CannEpil™?—?CBD-based

Epilepsy 100

Epilepsy Pharmaceutical Research and Development CBD 100

Puff Puff Post

OCTOBER 3, 2019

Previous success from treating epilepsy with Cannabinoids now motivates doctors to investigate the plant’s effectiveness in treating symptoms of autism. In a 47 acre greenhouse – close to the size of 42 football fields – GW is developing and delivering strains of medicinal cannabis.

Research and Development 94

Research and Development Epilepsy Clinical Trials Treatment 94

MGC Pharma

FEBRUARY 15, 2018

A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals Right now in Australia, access to Cannabis-based treatments is heavily restricted. Physicians who want to prescribe Medicinal Cannabis are required to jump through countless regulatory hoops, as are patients seeking treatment.

Access 100

Access Medicine Chronic Pain Research and Development 100

CannaMD

AUGUST 19, 2020

Researchers with Microbiology and Molecular Biology Reviews elaborate: The term “cytokine storm” calls up vivid images of an immune system gone awry and an inflammatory response flaring out of control. ” And their alternative strategy of choice? SARS-CoV2 is the virus that causes COVID-19.). Terpenes and CBD: Twice as Effective.

Research and Development 141

Research and Development Marijuana Extraction Terpenes 141

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. tetrahydrocannabinol (THC).

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

United Patients Group

JULY 7, 2023

While there is still much research to be done on the potential benefits and risks of medical cannabis, there is a growing body of evidence that suggests it can be a valuable tool for managing chronic pain, anxiety and depression, nausea and vomiting, seizures, inflammation, sleep, and other health conditions.

Chronic Pain 105

Chronic Pain Sleep Epilepsy Conditions 105

Puff Puff Post

DECEMBER 28, 2018

The Current Treatments for Autism. Most education-based autism treatment is focused on teaching developing children self-care, communicative, and social skills. Most education-based autism treatment is focused on teaching developing children self-care, communicative, and social skills. Instead, CBD is being used.

Treatment 76

Treatment Oil CBD Therapy 76

Cannabis Law Report

JULY 26, 2021

SciSparc intends to evaluate the efficacy, safety and tolerability of its Proprietary Cannabinoid-Based Treatment- SCI-110. The company has begun preparation that will facilitate the commencement of the clinical study and engaged with a contract research organization (CRO) to provide support for the trial.

Research and Development 105

Research and Development Supply Chain Pharmaceutical Treatment 105

MMJ Recs

DECEMBER 28, 2023

In recent years, a significant shift has occurred in the perception of medical marijuana, transforming it from a controversial substance to a recognized and, in some places, a legal form of medical treatment. Epidiolex, a CBD-based medication, has even received FDA approval for the treatment of specific seizure disorders.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

Greencamp

AUGUST 16, 2018

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Exploring the available research on ALS and cannabinoids. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies).

Strains 94

Strains Cannabinoids Research and Development Indica 94

The Cannigma

JUNE 15, 2021

Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Cancer patients suffer not only from cancer, but the damaging effects of treatment. Cannabis Cancer Treatments as an Alternative to Opioids.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

Veriheal

DECEMBER 28, 2021

Over the last few decades, the cannabis plant and its many components have been the focal point of research and stiff debate. D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Cannabis Law Report

AUGUST 2, 2021

OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain. TEL AVIV, Israel , Aug. ” About The Study.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Veriheal

FEBRUARY 24, 2021

Unfortunately, this had a powerful impact on a small subset of residents—UK children suffering from epilepsy who had been dependent on imported medications to help control their illness. But for some children, especially those struggling to manage severe epilepsy, cannabis and cannabis-based medications have proven to be a powerful tool.

Epilepsy 52

Epilepsy Oil Research and Development Topical 52

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. Support for Patient Well-Being The availability of medical marijuana in local communities fosters an environment of support for patients seeking alternative treatments.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

The Cannigma

JUNE 29, 2021

Though the distinction between these terms may seem trivial at first glance, it is in fact crucial for cannabis research, and therefore also for consumers and regulators as well. Researchers conducting survey based studies today often only have access to the THC concentration of the cannabis that their participants are using.

Terpenes 138

Terpenes Research and Development Cannabinoids Concentrates 138

Cannabis Law Report

SEPTEMBER 28, 2021

DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Insight, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. This Epilepsy – Pipeline Insight, 2021 provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Epilepsy pipeline landscape.

Epilepsy 40

Epilepsy Clinical Trials Research and Development Pharmaceutical 40

Cannabis Law Report

NOVEMBER 22, 2021

Thailand’s Public Health Ministry has signed a Memorandum of Understanding (MOU) with RxLeaf World Medica on establishing the International Medical Cannabis Research Center. The latest movement is a part of Thailand’s plan to be a world-class cannabis production and development hub. For more information [link].

Research and Development 52

Research and Development Epilepsy Cannabis Food 52

Veriheal

SEPTEMBER 27, 2021

Medical cannabis has been legal in the nation for almost three years—so why are MS patients struggling to access the treatment? A survey conducted by researchers in 2017 revealed that more than 40% of MS patients use medical cannabis. . 1, MS Society UK posted on Twitter , “Getting the treatment you need shouldn’t be a game of chance.

Treatment 98

Treatment Patients Access Research and Development 98

The Herb Collective

AUGUST 1, 2023

Reduces Anxiety and Depression: For those dealing with anxiety and depression, finding an effective treatment can be a daunting task. While the exact mechanisms behind this phenomenon are still being researched, the results are promising.

Indica 87

Indica Blood Pressure Epilepsy Sleep 87

PrestoDoctor

SEPTEMBER 26, 2023

Research suggests that cannabis can affect various aspects of mental health , including mood, cognition, and behavior. It’s important to note that not everyone who uses cannabis will develop mental health issues. Research suggests that there is indeed a link between cannabis use and mental health issues.

Research and Development 105

Research and Development Chronic Pain Sleep Conditions 105

Cannabis Law Report

DECEMBER 3, 2021

We look forward to sharing clinical trial data supporting the potential of ganaxolone to treat a range of seizure disorders as well as research data highlighting the impact that seizures can have on developmental progressions and quality of life in children with CDD.”. at the end of the 17 weeks of ganaxolone treatment.

Epilepsy 40

Epilepsy Pharmaceutical Data Clinical Trials 40

United Patients Group

APRIL 18, 2023

However, there are still many myths about cannabis that persist despite being debunked by medical professionals and researchers alike. While it can be used to treat many different conditions and symptoms, it’s important to note that not everyone will respond positively to medical cannabis treatment. Myth: Cannabis is just a drug.

Research and Development 116

Research and Development Indica Treatment Conditions 116

Cannabis Law Report

JANUARY 16, 2022

Sativex was developed by GW Pharmaceuticals, a maker of cannabinoid therapeutics based in Ireland. This means Malaysia currently has no registered marijuana-based treatment. Ketum is regulated under the Third Schedule of the Poisons Act that regulates drugs and medicines.

Pharmaceutical 98

Pharmaceutical Research and Development Epilepsy Medicine 98

Veriheal

OCTOBER 19, 2022

Warastuti, the mother of Pika Sasi Kirana, is actively lobbying for legal access and research into the plant alongside her daughter’s father, Sunarta. pounds) at birth, Pika developed into a healthy young toddler and progressed to kindergarten without any problems. Weighing 3.4 kilograms (7.5 Nothing worked.”

Legalization 105

Legalization Research and Development Chronic Pain Treatment 105

United Patients Group

FEBRUARY 8, 2023

Natural opioids include opium or poppy seeds; synthetic ones were first developed in 1950s by German chemist Paul Janssen, who went on to found Janssen Pharmaceutica NV (now part of Johnson & Johnson). Cannabis is one such treatment. There was also moderate evidence that they may help reduce nausea from chemotherapy treatments.

Chronic Pain 105

Chronic Pain Cannabinoids Research and Development Patients 105

MMJ Recs

MAY 25, 2024

Medical marijuana has been a hot topic over the years – from the stigma it surrounds the cannabis industry to its legalization in US states and its research and use for treating various ailments. However, further studies are needed to fully understand the mechanisms and potential of ECS modulation in mental health treatment.

Patients 105

Patients Marijuana Cannabinoids Chronic Pain 105

Cannabis Law Report

JUNE 5, 2019

The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Effective, most effective in treatment Relieve symptoms.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40